Selective Serotonin Reuptake Inhibitors (SSRIs) are types of antidepressants. Brand names of SSRIs include: Paxil, Zoloft, Celexa, Prozac, Lexapro, Symbyax, Wellbutrin and Effexor. These drugs inhibit neuronal serotonin and norepinephrine reuptake and slightly inhibit dopamine reuptake. SSRIs have been associated with serious, life-threatening birth defects. Research suggests that, if a mother took SSRI’s during pregnancy, […]
SC AG Files Lawsuit Against GSK for Improper Marketing of Diabetes Drug
June 3, 2011
Drug Regulators in the US and Europe Restrict Use of Avandia (rosiglitazone)
September 23, 2010
NHTSA Raises Number of Deaths Associated with Toyota Acceleration
May 26, 2010
Toyota Pays $16.4 Million Fine
May 19, 2010
Toyota Announces Plan to Replace Accelerators in Secondary Recall
March 23, 2010
Yasmin “Yaz” Birth Control
Yasmin and Yaz were approved by the Food & Drug Administration for women to use as a birth control pill. The generic name for Yasmin is “Ocella.” Unlike many drugs which are marketed strictly to doctors, Yaz and Yasmin were marketed directly to women, particularly targeting young women. Television ads promised to treat the pain and discomfort associated with premenstrual syndrome and acne. In 2008, the FDA stepped in and directed the company to discontinue the advertisements and correct the deceptive claims that had been made in these commercials.
More recently, Yaz has been associated with serious injuries caused by blood clots such as:
Heart Attack
Stroke
Gallbladder Disease
Kidney Stones
Pulmonary Embolism
Deep Vein Thrombosis
Liver, Kidney or Other Organ Failure
Death
Yasmin, Yaz and Ocella are new “combination” birth control pills made from estrogen (ethinyl estradiol), which affect the release of eggs, and progestin (drospirenone), which interferes with the lining of the uterus. Birth control pills alter the body’s chemistry so that, if an egg is released, it is harder to fertilize and more difficult to implant.
Researchers believe that drosperinone causes high potassium levels in users called hyperkalemia, which can lead to heart problems, stroke, pulmonary embolism, deep vein thrombosis and other injuries.
A number of women who have used Yaz, Yasmin or Ocella have developed gallstones and gallbladder disease. Scientists think that increased levels of potassium may be a factor in this as well.
We believe that Bayer, Berlex, Inc. and Berlex Laboratories (the companies that made and marketed Yaz, Yasmine and Ocella) failed to warn women about the potential side affects of Yaz and failed to test and research Yaz before placing it on the market.
This is not the first time that a drug has been promoted, perhaps over-promoted, to a female audience without adequate testing or proper warnings. We have recovered millions of dollars for people who were injured or died as a consequence of dangerous drugs that were not properly evaluated before being placed on the market.
Our experience can make the process of review and recovery as simple as possible for you.
First, when did you begin taking Yaz, Yasmin or Ocella?
Second, how long did you take Yaz, Yasmin or Ocella?
Third, what injury did you suffer?
It’s that easy. We can handle the rest with a short conversation and collection of your medical records. Our attorneys will keep you informed about the progress of your case. We are only a mouse click or telephone call away from answering any of your questions.
You can fill out the short form below or call us at 800-642-5297. Our firm is located in Pittsburgh Pennsylvania, but our practice in this type of case is literally worldwide. Bayer’s headquarters is located in Pittsburgh so we are uniquely positioned to promptly and aggressively pursue your claim to conclusion.